A bill to shield FDA's user fees from sequestration that took out an estimated $85 million in 2013 was reintroduced by Reps. Anna Eshoo (D-CA) and Leonard Lance (R-NJ) on Wednesday (Feb. 25). Industry groups praised the bill, saying broadly that protecting user fees from sequestration would help FDA approve drug, biologic, biosimilar, medical device and diagnostic products more quickly. The bill, called the FDA Safety Over Sequestration Act, would simply insert a clause in the Balanced Budget and Emergency...